SANA -Sana Biotechnology, Inc.

Name : Sana Biotechnology, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $0.00000000000000

EPSttm :

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=SANA #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

SANA — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

21.85

Margin Of Safety %

Put/Call OI Ratio

0.18

EPS Next Q Diff

-0.02

EPS Last/This Y

0.08

EPS This/Next Y

0.04

Price

2.43

Target Price

9.38

Analyst Recom

1.2

Performance Q

-35.54

Upside

-383.5%

Beta

2.3

Ticker: SANA

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	SANA	2.62	0.13	0.04	43065
2026-10-13	SANA	2.4	0.13	0.87	43046
2026-10-14	SANA	2.33	0.13	1.19	43053
2026-10-15	SANA	2.47	0.13	0.00	43026
2026-10-16	SANA	2.28	0.13	0.23	43166
2026-10-19	SANA	2.29	0.18	0.00	27390
2026-10-20	SANA	2.35	0.18	0.02	28043
2026-10-21	SANA	2.35	0.17	0.11	28581
2026-10-22	SANA	2.36	0.17	0.00	28869
2026-10-23	SANA	2.32	0.17	0.39	28885
2026-10-26	SANA	2.36	0.17	0.00	28932
2026-10-27	SANA	2.47	0.17	0.01	28975
2026-10-28	SANA	2.64	0.17	0.01	29234
2026-10-29	SANA	2.68	0.17	0.14	29427
2026-10-30	SANA	2.56	0.16	0.46	30173
2026-11-02	SANA	2.39	0.17	0.01	31464
2026-11-03	SANA	2.45	0.17	0.00	31561
2026-11-04	SANA	2.56	0.17	0.00	31685
2026-11-05	SANA	2.31	0.17	0.07	31713
2026-11-06	SANA	2.35	0.17	0.00	32197
2026-11-09	SANA	2.47	0.18	0.02	32672
2026-11-10	SANA	2.43	0.18	0.08	32741
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	SANA	2.62	11.0	-	-0.59
2026-10-13	SANA	2.41	11.0	-	-0.59
2026-10-14	SANA	2.33	11.0	-	-0.59
2026-10-15	SANA	2.47	11.0	-	-0.59
2026-10-16	SANA	2.28	11.0	-	-0.59
2026-10-19	SANA	2.28	11.0	-	-0.59
2026-10-20	SANA	2.28	11.0	-	-0.59
2026-10-21	SANA	2.36	11.0	-	-0.59
2026-10-22	SANA	2.37	11.0	-	-0.59
2026-10-23	SANA	2.33	11.0	-	-0.59
2026-10-26	SANA	2.36	11.0	-	-0.59
2026-10-27	SANA	2.48	11.0	-	-0.59
2026-10-28	SANA	2.64	11.0	-	-0.59
2026-10-29	SANA	2.72	11.0	-	-0.59
2026-10-30	SANA	2.56	11.0	-	-0.59
2026-11-02	SANA	2.38	11.0	-	-0.59
2026-11-03	SANA	2.45	11.0	-	-0.59
2026-11-04	SANA	2.56	11.0	-	-0.59
2026-11-05	SANA	2.32	11.0	-	-0.59
2026-11-06	SANA	2.35	11.0	-	-0.59
2026-11-09	SANA	2.47	11.0	-	-0.59
2026-11-10	SANA	2.43	11.0	-	-0.59
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	SANA	0.00	0.95	20.73
2026-10-13	SANA	0.00	0.95	20.73
2026-10-14	SANA	0.00	0.95	20.73
2026-10-15	SANA	0.00	0.95	20.73
2026-10-16	SANA	0.00	0.95	20.73
2026-10-19	SANA	0.00	0.94	20.73
2026-10-20	SANA	0.00	0.94	20.73
2026-10-21	SANA	0.00	0.94	20.73
2026-10-22	SANA	0.00	0.94	20.73
2026-10-23	SANA	0.00	0.94	20.73
2026-10-26	SANA	0.00	0.19	20.73
2026-10-27	SANA	0.00	0.19	21.87
2026-10-28	SANA	0.00	0.19	21.87
2026-10-29	SANA	0.00	0.19	21.87
2026-10-30	SANA	0.00	0.19	21.87
2026-11-02	SANA	0.00	0.20	21.87
2026-11-03	SANA	0.00	0.20	21.87
2026-11-05	SANA	0.00	0.20	21.87
2026-11-06	SANA	0.00	0.20	21.87
2026-11-09	SANA	0.00	0.51	21.85
2026-11-10	SANA	0.00	0.51	21.85
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=SANA 589 360 ]

Last Quarter Act. EPS

-0.14

Avg. EPS Est. Current Quarter

-0.13

Avg. EPS Est. Next Quarter

-0.16

Insider Transactions

Institutional Transactions

0.51

Beta

2.3

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-93.9

Target Price

9.38

P/E

Forward P/E

PEG

P/S

P/B

4.04

P/Free Cash Flow

EPS

-0.53

Average EPS Est. Cur. Y

-0.59

EPS Next Y. (Est.)

-0.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.79

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-89.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=SANA 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=SANA 589 450 ]

◆ SANA Healthcare

$2.43

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

17/25

Volume

9/15

Valuation

12/20

TP/AR

2/10

Options

6/10

RSI

44.4

Range 1M

31.1%

Sup Dist

3.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

18/30

Estimates

0/20

Inst/Vol

3/15

Options

9/10

EPS Yr

43.6%

EPS NY

2.9%

52W%

5.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +286% upside

Quality

2/30

Valuation

16/30

Growth

13/25

Stability

5/10

LT Trend

1/5

Upside

+286%

Quality

SANA — P/E HistoricalBiotechnology

Sana Biotechnology, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 142

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modified, stem cell derived pancreatic islet cell therapy, which is in preclinical trial for the treatment of type 1 diabetes; SG293 and SG299, a CD8-targeted fusosome for the treatment of B cell hematologic malignancies and B cell mediated autoimmune diseases. The company has an option and license agreement with Beam Therapeutics Inc. for use of Beam's proprietary CRISPR Cas12b nuclease editing technology to research, develop, and commercialize engineered cell therapy products; and a license agreement with Harvard College to access certain intellectual property for the development of hypoimmune-modified cells. The company has a strategic collaboration with Mayo Clinic for the development of SC451, a hypoimmune-modified pancreatic islet cell therapy for type 1 diabetes. The company was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. Sana Biotechnology, Inc. was incorporated in 2018 and is headquartered in Seattle, Washington.

[News_SANA _Stock]

stock quote shares SANA -Sana Biotechnology, Inc. Stock Price stock today

news today SANA -Sana Biotechnology, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch SANA -Sana Biotechnology, Inc. yahoo finance google finance

stock history SANA -Sana Biotechnology, Inc. invest stock market

stock prices SANA premarket after hours

ticker SANA fair value insiders trading

SANA -Sana Biotechnology, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SANA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y